At what age can montelukast be administered for the prevention of asthma attacks in children?

Montelukast can be administered to children for the prevention of asthma attacks starting at 12 months of age. The medication is a leukotriene receptor antagonist that works by blocking substances in the body called leukotrienes, which cause asthma symptoms and inflammation. Evidence supports its use in young children to help manage and prevent asthma and allergic symptoms effectively.

Though other options mention ages younger than 12 months, montelukast is not approved for use in this age group due to insufficient data on safety and efficacy. It is important to follow appropriate guidelines for medication administration based on age to ensure both effectiveness and safety in pediatric populations.